Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker
Authors
Keywords
-
Journal
MOLECULAR & CELLULAR PROTEOMICS
Volume 16, Issue 6, Pages 998-1008
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2017-04-11
DOI
10.1074/mcp.m117.068577
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Proteome of Primary Prostate Cancer
- (2016) Diego Iglesias-Gato et al. EUROPEAN UROLOGY
- Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
- (2015) Xiaoyi Huang et al. EUROPEAN UROLOGY
- Claudin-4 SPECT Imaging Allows Detection of Aplastic Lesions in a Mouse Model of Breast Cancer
- (2015) M. Mosley et al. JOURNAL OF NUCLEAR MEDICINE
- Mass spectrometry of extracellular vesicles
- (2015) Gabriella Pocsfalvi et al. MASS SPECTROMETRY REVIEWS
- Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
- (2015) Sonia A. Melo et al. NATURE
- The emerging threat of multidrug-resistant Gram-negative bacteria in urology
- (2015) Hosam M. Zowawi et al. Nature Reviews Urology
- Identification and Validation of Potential New Biomarkers for Prostate Cancer Diagnosis and Prognosis Using 2D-DIGE and MS
- (2015) Cordelia Geisler et al. Biomed Research International
- Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease
- (2015) Jonathan C. Dunne et al. Clinical Proteomics
- CLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma
- (2015) Lei Jiang et al. Oncotarget
- Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer
- (2015) Antje Neeb et al. Oncotarget
- Tight Junction Proteins Claudin-3 and Claudin-4 Control Tumor Growth and Metastases
- (2015) Xiying Shang et al. NEOPLASIA
- Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel
- (2014) Adriana Amaro et al. CANCER AND METASTASIS REVIEWS
- A claudin 3 and claudin 4-targeted Clostridium perfringens protoxin is selectively cytotoxic to PSA-producing prostate cancer cells
- (2014) Victor Romanov et al. CANCER LETTERS
- Glycoproteomic Analysis of Prostate Cancer Tissues by SWATH Mass Spectrometry Discovers N-acylethanolamine Acid Amidase and Protein Tyrosine Kinase 7 as Signatures for Tumor Aggressiveness
- (2014) Yansheng Liu et al. MOLECULAR & CELLULAR PROTEOMICS
- ProteomeXchange provides globally coordinated proteomics data submission and dissemination
- (2014) Juan A Vizcaíno et al. NATURE BIOTECHNOLOGY
- Protter: interactive protein feature visualization and integration with experimental proteomic data
- (2013) Ulrich Omasits et al. BIOINFORMATICS
- Tight junction proteins: From barrier to tumorigenesis
- (2013) E. Aaron Runkle et al. CANCER LETTERS
- Extracellular vesicles: Exosomes, microvesicles, and friends
- (2013) Graça Raposo et al. JOURNAL OF CELL BIOLOGY
- In-depth mass spectrometric mapping of the human vitreous proteome
- (2013) Sebastian Aretz et al. Proteome Science
- Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials
- (2012) Alexander V. Vlassov et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- The Role of Genetic Markers in the Management of Prostate Cancer
- (2012) Atish D. Choudhury et al. EUROPEAN UROLOGY
- The State of the Human Proteome in 2012 as Viewed through PeptideAtlas
- (2012) Terry Farrah et al. JOURNAL OF PROTEOME RESEARCH
- Proteomic Analysis of Microvesicles Released by the Human Prostate Cancer Cell Line PC-3
- (2012) Kirsten Sandvig et al. MOLECULAR & CELLULAR PROTEOMICS
- The PRoteomics IDEntification (PRIDE) Converter 2 Framework: An Improved Suite of Tools to Facilitate Data Submission to the PRIDE Database and the ProteomeXchange Consortium
- (2012) Richard G. Côté et al. MOLECULAR & CELLULAR PROTEOMICS
- Exosomes as Biomarker Enriched Microvesicles: Characterization of Exosomal Proteins Derived from a Panel of Prostate Cell Lines with Distinct AR Phenotypes
- (2012) Elham Hosseini-Beheshti et al. MOLECULAR & CELLULAR PROTEOMICS
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
- (2012) Héctor Peinado et al. NATURE MEDICINE
- Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes
- (2012) Claire Corcoran et al. PLoS One
- Plasma-Derived Exosomal Survivin, a Plausible Biomarker for Early Detection of Prostate Cancer
- (2012) Salma Khan et al. PLoS One
- Beyond PSA: The Next Generation of Prostate Cancer Biomarkers
- (2012) J. R. Prensner et al. Science Translational Medicine
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation
- (2012) Hina Kalra et al. PLOS BIOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinoma
- (2011) Tanner L Bartholow et al. Diagnostic Pathology
- The Contemporary Concept of Significant Versus Insignificant Prostate Cancer
- (2011) Guillaume Ploussard et al. EUROPEAN UROLOGY
- EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
- (2011) Nicolas Mottet et al. EUROPEAN UROLOGY
- Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer
- (2011) Andrew J. Armstrong et al. EUROPEAN UROLOGY
- Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors
- (2011) W Walther et al. GENE THERAPY
- Proteomics-based signature for human benign prostate hyperplasia and prostate adenocarcinoma
- (2011) Alaiya INTERNATIONAL JOURNAL OF ONCOLOGY
- The changing therapeutic landscape of castration-resistant prostate cancer
- (2011) Timothy A. Yap et al. Nature Reviews Clinical Oncology
- Claudin expression is dysregulated in prostate adenocarcinomas but does not correlate with main clinicopathological parameters
- (2011) Cláudia Malheiros Coutinho-Camillo et al. PATHOLOGY
- Identification of Clinically Relevant Protein Targets in Prostate Cancer with 2D-DIGE Coupled Mass Spectrometry and Systems Biology Network Platform
- (2011) Ramesh Ummanni et al. PLoS One
- Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer
- (2011) Toshihiro Maeda et al. PROSTATE
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Exosomes as Biomarker Treasure Chests for Prostate Cancer
- (2010) Diederick Duijvesz et al. EUROPEAN UROLOGY
- Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer
- (2009) Jianghong Li et al. BMC CANCER
- Quantitative Proteomic Profiling of Prostate Cancer Reveals a Role for miR-128 in Prostate Cancer
- (2009) Amjad P. Khan et al. MOLECULAR & CELLULAR PROTEOMICS
- Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis
- (2009) Y.-H. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now